Evolent Health Inc (NYSE: EVH) on Friday, plunged -0.18% from the previous trading day, before settling in for the closing price of $11.40. Within the past 52 weeks, EVH’s price has moved between $10.82 and $35.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.32%. The company achieved an average annual earnings per share of -28.91%. With a float of $111.83 million, this company’s outstanding shares have now reached $115.01 million.
Let’s determine the extent of company efficiency that accounts for 4700 employees. In terms of profitability, gross margin is 13.54%, operating margin of -0.91%, and the pretax margin is -3.54%.
Evolent Health Inc (EVH) Breakdown of a Key Holders of the stock
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Evolent Health Inc is 4.06%, while institutional ownership is 110.57%. The most recent insider transaction that took place on Aug 22 ’24, was worth 731,790. In this transaction PRESIDENT of this company sold 23,693 shares at a rate of $30.89, taking the stock ownership to the 198,809 shares. Before that another transaction happened on Aug 23 ’24, when Company’s PRESIDENT sold 10,469 for $32.38, making the entire transaction worth $339,008. This insider now owns 188,340 shares in total.
Evolent Health Inc (EVH) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -28.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to -13.43% drop over the previous five years of trading.
Evolent Health Inc (NYSE: EVH) Trading Performance Indicators
Evolent Health Inc (EVH) is currently performing well based on its current performance indicators. A quick ratio of 1.04 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.54. Likewise, its price to free cash flow for the trailing twelve months is 12.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.96 in one year’s time.
Technical Analysis of Evolent Health Inc (EVH)
Looking closely at Evolent Health Inc (NYSE: EVH), its last 5-days average volume was 2.69 million, which is a jump from its year-to-date volume of 1.85 million. As of the previous 9 days, the stock’s Stochastic %D was 34.14%. Additionally, its Average True Range was 0.91.
During the past 100 days, Evolent Health Inc’s (EVH) raw stochastic average was set at 2.46%, which indicates a significant decrease from 20.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.10% in the past 14 days, which was lower than the 119.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.45, while its 200-day Moving Average is $24.63. However, in the short run, Evolent Health Inc’s stock first resistance to watch stands at $11.80. Second resistance stands at $12.22. The third major resistance level sits at $12.56. If the price goes on to break the first support level at $11.04, it is likely to go to the next support level at $10.70. Now, if the price goes above the second support level, the third support stands at $10.28.
Evolent Health Inc (NYSE: EVH) Key Stats
Market capitalization of the company is 1.32 billion based on 116,564K outstanding shares. Right now, sales total 1,964 M and income totals -113,040 K. The company made 621,400 K in profit during its latest quarter, and -23,140 K in sales during its previous quarter.
